Trial intelligence / Profile preview

Sirolimus vs Sirolimus + Tacrolimus in Islet Transplantation

NCT00409461Phase 2Terminated

Sponsor
AstraZeneca
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sirolimus in type 1 diabetes mellitus (T1D), sponsored by AstraZeneca. Status: terminated.

02

Drugs

sirolimus
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00409461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00409461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call